Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy

Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapy

Inhibition of PERK, an endoplasmic reticulum (ER) unfolded protein response (UPR) protein, is a potential pharmacological target for cancer treatment. Here, the authors show that inhibition of PERK under ER stress affects trafficking from the ER to the surface of several key receptor tyrosine kinase...

Full description

Bibliographic Details
Main Authors: Mohamed Mahameed, Shatha Boukeileh, Akram Obiedat, Odai Darawshi, Priya Dipta, Amit Rimon, Gordon McLennan, Rosi Fassler, Dana Reichmann, Rotem Karni, Christian Preisinger, Thomas Wilhelm, Michael Huber, Boaz Tirosh
Format: Article
Language:English
Published: Nature Portfolio 2020-03-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-020-15067-5

Internet

https://doi.org/10.1038/s41467-020-15067-5

Similar Items